Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology
Open Access
- 29 June 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 134 (10), 2982-3010
- https://doi.org/10.1093/brain/awr129
Abstract
Dravet syndrome is an epilepsy syndrome of infantile onset, frequently caused by SCN1A mutations or deletions. Its prevalence, long-term evolution in adults and neuropathology are not well known. We identified a series of 22 adult patients, including three adult post-mortem cases with Dravet syndrome. For all patients, we reviewed the clinical history, seizure types and frequency, antiepileptic drugs, cognitive, social and functional outcome and results of investigations. A systematic neuropathology study was performed, with post-mortem material from three adult cases with Dravet syndrome, in comparison with controls and a range of relevant paediatric tissue. Twenty-two adults with Dravet syndrome, 10 female, were included, median age 39 years (range 20–66). SCN1A structural variation was found in 60% of the adult Dravet patients tested, including one post-mortem case with DNA extracted from brain tissue. Novel mutations were described for 11 adult patients; one patient had three SCN1A mutations. Features of Dravet syndrome in adulthood include multiple seizure types despite polytherapy, and age-dependent evolution in seizure semiology and electroencephalographic pattern. Fever sensitivity persisted through adulthood in 11 cases. Neurological decline occurred in adulthood with cognitive and motor deterioration. Dysphagia may develop in or after the fourth decade of life, leading to significant morbidity, or death. The correct diagnosis at an older age made an impact at several levels. Treatment changes improved seizure control even after years of drug resistance in all three cases with sufficient follow-up after drug changes were instituted; better control led to significant improvement in cognitive performance and quality of life in adulthood in two cases. There was no histopathological hallmark feature of Dravet syndrome in this series. Strikingly, there was remarkable preservation of neurons and interneurons in the neocortex and hippocampi of Dravet adult post-mortem cases. Our study provides evidence that Dravet syndrome is at least in part an epileptic encephalopathy.Keywords
This publication has 81 references indexed in Scilit:
- The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission1Epilepsia, 2010
- Sodium channel gene family: epilepsy mutations, gene interactions and modifier effectsThe Journal of Physiology, 2010
- Altered Function of the SCN1A Voltage-gated Sodium Channel Leads to γ-Aminobutyric Acid-ergic (GABAergic) Interneuron AbnormalitiesJournal of Biological Chemistry, 2010
- Bilateral reorganization of the dentate gyrus in hippocampal sclerosisNeurology, 2009
- A Role of SCN9A in Human Epilepsies, As a Cause of Febrile Seizures and As a Potential Modifier of Dravet SyndromePLoS Genetics, 2009
- A BAC transgenic mouse model reveals neuron subtype-specific effects of a Generalized Epilepsy with Febrile Seizures Plus (GEFS+) mutationNeurobiology of Disease, 2009
- Temperature- and age-dependent seizures in a mouse model of severe myoclonic epilepsy in infancyProceedings of the National Academy of Sciences, 2009
- Sporadic Infantile Epileptic Encephalopathy Caused by Mutations in PCDH19 Resembles Dravet Syndrome but Mainly Affects FemalesPLoS Genetics, 2009
- Glial connexins and gap junctions in CNS inflammation and diseaseJournal of Neurochemistry, 2008
- X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairmentNature Genetics, 2008